When a GHRH analogue and a GHRP are administered together, they act on two independent receptor systems simultaneously, producing a synergistic effect on GH release that exceeds what either compound achieves alone
Arion 1997)
In the STEP 1 trial, participants using semaglutide 2.4 mg weekly (marketed as Wegovy) lost an average of 14.9% of their body weight over 68 weeks
Bello S, Bonali C, Serafino L et al (2014) Intra-articular therapy with tumor necrosis factor-alpha antagonists: an update
Perticone F, Ceravolo R, Pujia A, Ventura G, Iacopino S, Scozzafava A, Ferraro A, Chello M, Mastroroberto P, Verdecchia P, Schillaci G